| |
|
|
|
CymaBay Therapeutics Inc.  
|
|
1.88 -0.05 (-0.03%) |
01-23 09:51 |
|
Open: |
1.94 |
Pre close: |
1.93 |
Target:
|
2.33 
|
|
High: |
1.94 |
Low: |
1.86 |
Resistance:
|
2.00
2.18
|
|
Volume: |
79,607 |
Market Cap: |
129M |
Support:
|
1.70
1.41
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.95
 |
MACD |
MACD(12,26):
|
-0.14 |
|
MA(20): |
1.93 |
Signal(12,26,9): |
-0.20 |
|
MA(100): |
3.94 |
Stochastic Oscillator |
%K(14,3):
|
39.05 |
|
MA(250): |
7.49 |
%D(3): |
45.91 |
|
Average Volume(K) |
3-Month: |
225384
|
52-Week |
High:
|
14.00 |
|
10-Days: |
98680 |
Low: |
1.29 |
|
RSI |
RSI(14):
|
40.83 |
Change(%): |
-76.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.435 |
Return on Equity (ttm) |
-46.3 |
Shares Out. (M) |
68.70 |
|
EPS Est. Current Year |
-0.820 |
Return on Assets (ttm) |
-28.2 |
Shares Float (M) |
46.33 |
|
EPS Est. Next Year |
-0.740 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.62 |
|
EPS Est. Next Quarter |
-0.160 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
107.95 |
|
Forward EPS |
-0.940 |
Gross Profit (p.s.) |
-0.637 |
Shares Short (K) |
6800 |
|
Book Value (p.s.) |
3.090 |
EBITDA (p.s.) |
-1.422 |
P/E |
-1.34 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.62 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-89.37 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-54.14 |
P/CF |
-1.48 |
|
|
|
|
|
|
